ANCONRIN Trademark

Trademark Overview


On Tuesday, March 22, 2022, a trademark application was filed for ANCONRIN with the United States Patent and Trademark Office. The USPTO has given the ANCONRIN trademark a serial number of 79346360. The federal status of this trademark filing is REGISTERED as of Tuesday, June 20, 2023. This trademark is owned by SinoCellTech Ltd.. The ANCONRIN trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; medicines for human purpose, namely pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations, namely pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; dietetic beverages and foods adapted for medical use; medical diagnostic reagents; blood for medical purposes
anconrin

General Information


Serial Number79346360
Word MarkANCONRIN
Filing DateTuesday, March 22, 2022
Status700 - REGISTERED
Status DateTuesday, June 20, 2023
Registration Number7082742
Registration DateTuesday, June 20, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements


Goods and ServicesVaccines; medicines for human purpose, namely pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations, namely pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; dietetic beverages and foods adapted for medical use; medical diagnostic reagents; blood for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSinoCellTech Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCN

Party NameSinoCellTech Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameSinoCellTech Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Monday, October 16, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, September 25, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, September 25, 2023FINAL DISPOSITION PROCESSED
Wednesday, September 20, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 20, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 20, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 17, 2023NEW REPRESENTATIVE AT IB RECEIVED
Thursday, February 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 3, 2022REFUSAL PROCESSED BY IB
Saturday, September 10, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 9, 2022REFUSAL PROCESSED BY MPU
Friday, August 19, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 18, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 16, 2022ASSIGNED TO EXAMINER
Tuesday, August 2, 2022APPLICATION FILING RECEIPT MAILED
Friday, July 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 28, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB